Results 251 to 260 of about 83,254 (357)

Ruxolitinib cream for the treatment of granuloma annulare

JAAD Case Reports
Austin J. Piontkowski, BS, Nancy Wei, MD, Aisha Mumtaz, MD, Nicholas Gulati, MD, PhD   +3 more
doaj   +1 more source

Adult Acute Respiratory Distress Syndrome (ARDS) Caused by Human Rhinovirus During Janus Kinase Inhibitor Therapy for Rheumatoid Arthritis: A Case Report and Literature Review. [PDF]

Cureus
Choudhuri B, Patra S, Biswas P, Dasgupta A, Agarwal N, Das Thakur S.   +5 more
europepmc   +1 more source

Extracellular vesicles released from melanoma cells constitutively expressing MHC class II promote immune evasion and cancer progression

The FEBS Journal, EarlyView.
Here, we report the role of extracellular vesicles (EVs) released from melanoma cells constitutively expressing MHC class II in the regulation of immune cell functions and melanoma metastasis. In particular, we observed an increased localization of HLA‐DRα, CAM receptors, PD‐L1, and STAT3 signaling proteins in the EVs.
Francesca Costantini, Caterina Di Sano, Samuele Raccosta, Mauro Manno, Giovanna Barbieri   +4 more
wiley   +1 more source

Direct Effects of the Janus Kinase Inhibitor Baricitinib on Sensory Neurons. [PDF]

Int J Mol Sci
Vazquez E, Richter F, Natura G, König C, Eitner A, Schaible HG.   +5 more
europepmc   +1 more source

Brevilin A, a Novel Natural Product, Inhibits Janus Kinase Activity and Blocks STAT3 Signaling in Cancer Cells

, 2013
Xing Chen, Yuping Du, Nan Jing, Xinxin Zhang, Xiaodong Qin, Yuxin Wang, Jianwen Hou, Qin Wang, Jinbo Yang   +8 more
openalex   +2 more sources

Improvement in Patient‐Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO‐2b/3

International Journal of Dermatology, EarlyView.
ABSTRACT Background Patients with alopecia areata (AA) in ALLEGRO‐2b/3 (NCT03732807) had clinically significant hair regrowth and patient‐reported improvements with ritlecitinib versus placebo, but patient‐reported improvements in AA Patient Priority Outcomes (AAPPO) emotional symptoms (ES) or activity limitations (AL) were not observed during the 24 ...
Ernest H. Law, Bintu Sherif, Arash Mostaghimi, Brett King, Rodney Sinclair, Natasha Mesinkovska, Kent A. Hanson, Dane Korver, Costel Chirila   +8 more
wiley   +1 more source

Treatment of rheumatoid arthritis with janus kinase inhibitors [PDF]

Pernille Holme Thorhauge, Lars Løkke Ottesen, Niels Lomborg   +2 more
openalex   +1 more source

Safety and effectiveness of the combination of 5‐azacitidine and ruxolitinib in VEXAS syndrome: A single‐centre experience

British Journal of Haematology, EarlyView.
Gregorio Maria Bergonzi, Enrico Cozzo, Alessandro Tomelleri, Costanza Piccolo, Gianluca Scorpio, Carmelo Gurnari, Francesca Romano, Marco Matucci‐Cerinic, Lorenzo Dagna, Massimo Bernardi, Luca Vago, Fabio Ciceri, Corrado Campochiaro, Elisa Diral   +13 more
wiley   +1 more source

Corrigendum to 'Combination of Janus kinase inhibitor and biologic for recalcitrant severe atopic dermatitis'. [PDF]

J Eur Acad Dermatol Venereol
europepmc   +1 more source

Biomimetic polydopamine loaded with janus kinase inhibitor for synergistic vitiligo therapy via hydrogel microneedles. [PDF]

J Nanobiotechnology
Li C, Wang W, Shao J, Zhou S, Ji X, Xi Y, Xu Q, Huang Y, Wang J, Wan Y, Li Z.   +10 more
europepmc   +1 more source